Top U.S. drug maker Pfizer just reported its second quarter earnings report that beat the Street. The company saw a profit rise of up to 50% in the quarter thanks to the help of rising sales in most of its key drugs. These drugs included Lyrica, and a new breast cancer drug called Ibrance, as … Continue reading “Pfizer Sees a 50% Rise in Profit with the Help of These Drugs”
